SEC Form 4/A · accession 0001615774-18-013143
Emmaus Life Sciences, Inc. · EMMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Period of report
Oct 8, 2018
Accepted (ET)
Nov 21, 2018 · 4:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000822370
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCKF1 | Oct 8, 2018 | A | 144,000 | $1.38 | A | 1,056,474 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On October 8, 2018, the Reporting Person acquired the 144,000 shares of restricted common stock because Michal Votruba immediately and automatically assigned all benefits resulting from an October 8, 2018 grant of restricted common stock to the Reporting Person pursuant to the policies of the Reporting Person regarding stock ownership by its employees, as documented by an Agreement between Michal Votruba and the Reporting Person. Michal Votruba was entitled to acquire the shares under the MYnd Analytics, Inc. Amended and Restated 2012 Omnibus Incentive Compensation Plan. Michal Votruba is serving on the Board of MYnd Analytics, Inc. at the request of the Reporting Person.
Remarks
/s/ Libor Winkler, chairman of the board of directors of RSJ Investments investicni spolecnost a.s., a company serving as a member of the board of RSJ Investments SICAV a.s. acting in respect of its sub-fund (podfond) RSJ Gradus podfond, RSJ Investment SICAV a.s.